obesity drug news today glp-1 today health pharma drugs october 2025 Outlook for obesity in 2025: more Are you eligible? Medicare's new

While glucagon-like peptide-1 (GLP-1) medications are known to improve sleep apnea in patients with obesity, the study found that not all patients benefit equally

Tackling weight loss does not have to come with the risk of drug side effects

Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials

The partnership was disclosed by Humana and Novo Nordisk that CenterWell Pharmacy will be its fulfillment partner for NovoCare, a pharmacy the drug maker launched a month ago to provide direct-to-patient, convenient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients, Novo Nordisk said last month

These findings confirmed that GLP-1RA had a certain influence on the occurrence and development of tumors

Two common problems stand out